Nadja Boukhedouni

An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial

D. Foell, A. Belot, I. Koné-Paut, 2022, Journal of Clinical Immunology.

An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial

D. Foell, A. Belot, I. Koné-Paut, 2022, Journal of Clinical Immunology.

Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin–Resistant Kawasaki Disease

B. Cherqaoui, A. Belot, I. Marie, 2020, Arthritis & rheumatology.